U.S. Markets open in 1 hr 42 mins
  • S&P Futures

    4,053.25
    -22.25 (-0.55%)
     
  • Dow Futures

    34,292.00
    -167.00 (-0.48%)
     
  • Nasdaq Futures

    11,953.50
    -56.75 (-0.47%)
     
  • Russell 2000 Futures

    1,885.20
    -9.20 (-0.49%)
     
  • Crude Oil

    81.96
    +1.98 (+2.48%)
     
  • Gold

    1,807.50
    -2.10 (-0.12%)
     
  • Silver

    23.17
    -0.08 (-0.32%)
     
  • EUR/USD

    1.0574
    +0.0043 (+0.4124%)
     
  • 10-Yr Bond

    3.5060
    0.0000 (0.00%)
     
  • Vix

    20.16
    +0.32 (+1.61%)
     
  • GBP/USD

    1.2299
    +0.0003 (+0.0221%)
     
  • USD/JPY

    135.1820
    +0.9110 (+0.6785%)
     
  • BTC-USD

    17,256.84
    +290.78 (+1.71%)
     
  • CMC Crypto 200

    409.05
    +7.63 (+1.90%)
     
  • FTSE 100

    7,570.73
    +14.50 (+0.19%)
     
  • Nikkei 225

    27,820.40
    +42.50 (+0.15%)
     

Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript

Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript

At this time, I would like to welcome everyone to the Arbutus Biopharma 2022 second quarter financial results and corporate update. Good morning, everyone, and thank you for joining our second quarter 2022 financial results and corporate update call. Joining me today from the Arbutus executive team are Bill Collier, president and chief executive officer; David Hastings, chief financial officer; Dr. Gaston Picchio, chief development officer; and Dr.